"OneScreen" Drug Test Devices: Adulterant Effects and Untrained Subject Use.
Objective: To evaluate the CLIA-waived immunochromatographic lateral flow assay "OneScreen" drug test device from American Screening Corporation for its ability to perform accurately in the presence of urine specimen adulterants and to evaluate the ability of untrained subjects to perform the assay...
| Publicado en: | Clinical Laboratory Science Vol. 29; no. 1; pp. 9 - 16 |
|---|---|
| Autores principales: | , , |
| Formato: | research tables/charts Journal Article |
| Publicado: |
American Society for Clinical Laboratory Science
Winter2016
|
| Acceso en línea: | Ver este registro en EBSCOhost |